£139.86

Humana Myeloma Bone Disease (Current Clinical Oncology)

Price data last checked 63 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 28 days • 28 data points (No recent data available)

Historical
Generating forecast...
£139.86 £139.53 £139.60 £139.67 £139.75 £139.82 £139.89 25 January 2026 31 January 2026 07 February 2026 14 February 2026 21 February 2026

Price Distribution

Price distribution over 28 days • 1 price levels

Days at Price
28 days 0 7 14 21 28 £140 Days at Price

Price Analysis

Most common price: £140 (28 days, 100.0%)

Price range: £140 - £140

Price levels: 1 different prices over 28 days

Description

Multiple myeloma is the second most common hematologic malignancy and c- rently affects approximately 50,000 people in the United States. Each year about 20,000 people are diagnosed with myeloma. Although new treatments have been developed, which signi?cantly prolong the survival of patients, myeloma bone d- ease still remains a major cause of severe morbidity and increased mortality in patients with myeloma. Myeloma bone disease is characterized by "punched out" lytic lesions caused by increased osteoclastic bone destruction accompanied by suppressed or even absent osteoblast activity. Advances in our understanding of both the pathophysiology of myeloma bone disease and the development of novel agents that target speci?c pathways involved in both the increased osteoclast f- mation and the suppressed osteoblast activity in myeloma provide new hope for these patients. The treatment of myeloma bone disease was revolutionized by cl- ical trials that demonstrated the signi?cant bene?t of intravenous bisphosphonate therapy in patients with myeloma bone disease. With the identi?cation of many of the cytokines and chemokines involved in myeloma bone disease, novel th- apies such as denosumab that blocks RANKL activity, anti-DKK1, which targets the inhibition of osteoblast activity by blocking Wnt signaling inhibition, and the potential anabolic effects of agents such as bortezomib and activin have greatly improved our potential to block the progression or reverse myeloma bone disease.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)
95% match

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

CRC Press

£81.99 01 Mar 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
94% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.41 10 Mar 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
94% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£67.40 09 Mar 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
94% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.43 01 Mar 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
94% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
94% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£134.20 11 Jan 2026
Bone Cancer: Progression and Therapeutic Approaches
94% match

Bone Cancer: Progression and Therapeutic Approaches

Academic Press

£69.84 24 Feb 2026
Myeloma Bone Disease (Current Clinical Oncology)
94% match

Myeloma Bone Disease (Current Clinical Oncology)

Humana

£154.94 11 Jan 2026
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
93% match

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Springer

£109.79 22 Feb 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
93% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£79.70 22 Feb 2026
Humana Osteoporosis: Pathophysiology and Clinical Management
93% match

Humana Osteoporosis: Pathophysiology and Clinical Management

Humana

£122.54 06 Mar 2026
Treatment of Multiple Myeloma and Related Disorders
93% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 27 Feb 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
93% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 06 Jan 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
93% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Academic Press

£166.49 25 Jan 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
93% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£84.59 08 Mar 2026
Acute Myelogenous Leukemia (Contemporary Hematology)
93% match

Acute Myelogenous Leukemia (Contemporary Hematology)

Humana

£164.16 09 Jan 2026
Bone Cancer: Primary Bone Cancers and Bone Metastases
93% match

Bone Cancer: Primary Bone Cancers and Bone Metastases

Academic Press

£102.19 25 Feb 2026
Hematologic Malignancies: An Overview - Hematology Research
93% match

Hematologic Malignancies: An Overview - Hematology Research

Out of Stock 17 Apr 2026
Horizons in Cancer Research. Volume 73: Volume 73
93% match

Horizons in Cancer Research. Volume 73: Volume 73

£116.24 11 Jan 2026
Bone Metastasis: Experimental and Clinical Therapeutics (Cancer Drug Discovery and Development)
93% match

Bone Metastasis: Experimental and Clinical Therapeutics (Cancer Drug Discovery and Development)

Humana

£98.17 24 Feb 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
93% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£71.41 22 Feb 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
93% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£102.58 08 Jan 2026
Current Advances in Osteosarcoma: 804 (Advances in Experimental Medicine and Biology)
92% match

Current Advances in Osteosarcoma: 804 (Advances in Experimental Medicine and Biology)

Springer

£96.75 27 Feb 2026
Bone Marrow: A Practical Manual (Vademecum)
92% match

Bone Marrow: A Practical Manual (Vademecum)

CRC Press

£52.99 19 Apr 2026